Apple Watch Series 9 and Ultra 2 face SpO2 sensor loss in US patent dispute

Masimo's victory in US court over Apple has led the Cupertino giant to consider a drastic workaround to the implications that it may have its newest Watches effectively banned from sale in the United States on a more permanent basis.

According to a new Bloomberg report, this latest strategy is to negate the SpO2 sensing technology at the heart of the dispute by disabling it in the Series 9 and Ultra 2 soon. Brand new units of the wearables might even have their hardware altered in order to comply with this initiative.

Blood oxygen sensing or tracking features have been around for some time, and might thus be seen as an almost baseline spec in a new smartwatch (or ring, even). Nevertheless, Apple's new alleged plan might seem preferable to having its latest wearables removed from its native market altogether.

Then again, it is also reportedly a contingency in the event its upcoming appeal against the verdict in favor of Masimo should fail.

Buy a first-gen Series 8 Renewed for a potentially reduced price instead on Amazon